![](https://rakesh-jhunjhunwala.in/wp-content/uploads/Caplin-Point2-e1476983813470-100x100.jpg)
Mudar Patherya has put a little known small-cap on the center stage and confidently predicted that it will be “the next Ajanta Pharma”. The stock boasts of impeccable credentials and is well on the way to proving Mudar’s prediction correct
Ashish Kacholia’s favourite tech stock, which is said to have huge “untapped opportunity”, has been battered out of shape owing to soft quarterly results. Leading experts have explained that the fall in the stock price offers us the golden opportunity to tuck into the stock and wait patiently for multibagger gains to unfold
Basant Maheshwari has homed in on a top-quality micro-cap which has all the qualities that one seeks in a winning stock. It has a monopoly product, zero debt, high RoEs and reasonable valuations. The stock is already a mega multibagger but has still a long way to go given the infinite demand for its products
EvoLve theme by Theme4Press • Powered by WordPress & Rakesh Jhunjhunwala Rakesh Jhunjhunwala
Fan Site: Inspired, Not Endorsed, By Rakesh Jhunjhunwala
Recent Comments